Connective Capital Management’s Oncolytics Biotech ONCY Stock Holding History
Bought
Maintained
Sold
Other funds holding ONCY
IAIM
Connective Capital Management's ONCY Position: Q3 2026 in Review
Connective Capital Management sold out of Oncolytics Biotech (ONCY) in Q3 2026, closing a stake of 185,712 shares — an estimated $176K sold.
Connective Capital Management first reported a position in ONCY in Q4 2025 and held it in 2 quarters. The position peaked at $176K in Q2 2026. 77 funds tracked by Wall St. Rank hold ONCY as of Q3 2026.
- Connective Capital Management reported no remaining Oncolytics Biotech position as of Q3 2026 after selling out during the quarter.
- Connective Capital Management sold 185,712 Oncolytics Biotech shares in Q3 2026, an estimated $176K.
- Connective Capital Management first reported a position in Oncolytics Biotech in Q4 2025 and held it in 2 quarters.
- Connective Capital Management's Oncolytics Biotech position peaked at $176K in Q2 2026.
- 77 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q3 2026.
Based on Connective Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.